IGI licenses Nova Skin dermatologist sales duties to "major" drug company.
This article was originally published in The Rose Sheet
Executive SummaryIGI ACTIVEL SKIN CARE LINE TO BOW IN 1997 in the salon/esthetician market. IGI is working on the skin care line, which employs the company's patented Novasome lipid microvesicle technology, with San Jose, Calif.-based Image Enhancing Dermatology (IED), a physician group partnership that specializes in medical and cosmetic dermatology. IGI and IED announced their partnership Aug. 21 ("The Rose Sheet" Aug. 26, p. 6)
You may also be interested in...
The US FDA has slapped a partial clinical hold on Ipsen’s palovarotene clinical trials in rare bone disorders in children less than 14 years old, due to bone growth concerns.